» Articles » PMID: 38108966

Native and Ion Mobility Mass Spectrometry Characterization of Alpha 1 Antitrypsin Variants and Oligomers

Overview
Specialty Molecular Biology
Date 2023 Dec 18
PMID 38108966
Authors
Affiliations
Soon will be listed here.
Abstract

In this chapter, we describe a method for analyzing both recombinant and plasma-derived alpha 1 antitrypsin and its oligomers by means of native ion mobility mass spectrometry. Our experimental workflow can be applied to other variants of alpha 1 antitrypsin and its oligomers as well as being used to probe their interactions with small molecules in the gas phase.

References
1.
Gabelica V, Shvartsburg A, Afonso C, Barran P, Benesch J, Bleiholder C . Recommendations for reporting ion mobility Mass Spectrometry measurements. Mass Spectrom Rev. 2019; 38(3):291-320. PMC: 6618043. DOI: 10.1002/mas.21585. View

2.
Hopper J, Oldham N . Collision induced unfolding of protein ions in the gas phase studied by ion mobility-mass spectrometry: the effect of ligand binding on conformational stability. J Am Soc Mass Spectrom. 2009; 20(10):1851-8. DOI: 10.1016/j.jasms.2009.06.010. View

3.
Powell L, Pain R . Effects of glycosylation on the folding and stability of human, recombinant and cleaved alpha 1-antitrypsin. J Mol Biol. 1992; 224(1):241-52. DOI: 10.1016/0022-2836(92)90587-a. View

5.
Lomas D, Irving J, Arico-Muendel C, Belyanskaya S, Brewster A, Brown M . Development of a small molecule that corrects misfolding and increases secretion of Z α -antitrypsin. EMBO Mol Med. 2021; 13(3):e13167. PMC: 7933930. DOI: 10.15252/emmm.202013167. View

6.
Carrell R, Lomas D . Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med. 2002; 346(1):45-53. DOI: 10.1056/NEJMra010772. View